JMIR Publications

ABSTRACT

Low-frequency vibrotactile stimulation has often been discussed as haptic feedback, as relaxation, as low-frequency vibroacoustic therapy, or as an adjunct to rehabilitation. In recent years, however, evidence has accumulated that tactile and rhythmic sensory stimulation may relate to health-relevant outcomes including pain, anxiety, depression, autonomic regulation, sleep, cognition, and age-related function. This Viewpoint argues that structured tactile stimulation should be studied as a candidate noninvasive somatosensory neurotechnology. The claim is not that disease-specific efficacy has been established for any particular device or signal protocol. It is that tactile stimulation can be designed, parameterized, delivered reproducibly, and evaluated as a controllable somatosensory interface. The central focus of this paper is somatosensory input; low-frequency acoustic presentation is treated as one physical transmission route by which such input is produced. When a sound-pressure fluctuation acts on the body surface, mechanical displacement of that surface follows, corresponding to that fluctuation: this is physically necessary. The question is therefore not whether displacement occurs, but with what amplitude and waveform, and at what level it drives which afferent pathway. Accordingly, this paper attributes no therapeutic meaning to any particular frequency. The choice of 40 Hz in the author’s work was based, in the contact-based system, on the tactile judgment of a skilled practitioner and, in the airborne system, on the practical lower reproduction limit of the delivery equipment. It carries no theoretical implication. The argument rests primarily on external peer-reviewed evidence: touch interventions, device-mediated touch, low-frequency vibrotactile stimulation in dementia care, low-frequency vibroacoustic stimulation, rhythmic bodily stimulation, and 40 Hz sensory stimulation. The author’s own research program—tactile informatics and the Tactile Score, acoustically converted vibrotactile delivery of signals derived from the human hand, low-frequency components purified from natural sound fields, clinical work in mild cognitive impairment and mild dementia, preclinical work in an aging model, and a face-directed platform—is presented as one implementation route within that wider context. Rather than reducing the field to a single frequency or application, the paper proposes a research agenda for defining stimulus parameters, mechanistic endpoints, safety profiles, and clinically meaningful outcomes.